Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Chronimed Announces Second Quarter Fiscal 1999 Results
MINNEAPOLIS, January 26, 1999 -- Chronimed Inc. (Nasdaq: CHMD) , today announced record second quarter revenue and net income for the period ended January 1, 1999. Chronimed reported record revenue for the second quarter ended January 1, 1999 of $48.7 million, up 40 percent from $34.8 million in
Toggle Summary Chronimed Announces Further FDA Clearance On Lasetteā„¢ Product For Screening Blood Tests
MINNEAPOLIS, January 25, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that the Food and Drug Administration (FDA) has cleared the Lasetteā„¢ laser finger perforator system for use in drawing blood for screening purposes. Previously cleared for blood glucose testing purposes, the Lasette is
Toggle Summary Chronimed Presents At H&Q Healthcare Conference
MINNEAPOLIS, January 12, 1999 -- Chronimed Inc. (Nasdaq: CHMD) , today made a presentation to investors at the Hambrecht & Quist 17th Annual Healthcare Conference in San Francisco. Chronimed is a leading integrated healthcare company specializing in diagnostic products, pharmacy services and
Toggle Summary Chronimed Launches Life Management Programsm For Transplant Members
New Program Has the Potential to Reduce Preventable Healthcare Costs Due to Non-Compliance By Millions of Dollars NEWS RELEASE MINNEAPOLIS, January 11, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today the launch of The Life Management ProgramSM for Transplant Members, a program that will, if
Toggle Summary Chronimed Announces Record First Quarter Fiscal 1999 Results
MINNEAPOLIS, October 21, 1998 -- Chronimed Inc. (Nasdaq: CHMD) , today announced first quarter revenue and net income for the period ended October 2, 1998. Chronimed reported record revenue for the first quarter ended October 2, 1998 of $42.8 million, up 35 percent from $31.7 million in last year's